Physician

Shariar Cohen-Gadol, M.D.

According to 2025 Medicare claims, Shariar Cohen-Gadol, M.D. (NPI: 1013054865) practices rheumatology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is SHARIAR COHEN MD CORP (NPI: 1831331073; TIN: 260167782) and primary practice location at 91360-3953. Cohen-Gadol is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Cohen-Gadol's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,604 traditional Medicare patients, billed 705,420 HCPCS/CPT codes, and received $8,685,547 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,598 prescription claims across 946 beneficiaries totaling $4,709,539 in drug costs, led by Rinvoq (Upadacitinib). DME data shows 26 claims. Open Payments data shows 378 records totaling $73,816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,601,171 to $8,685,547. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,526,677 to $4,709,539. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,443 to $1,818.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.3M$8.7M2015 Medicare payment: $3,601,171 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,415,156 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,332,051 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,302,929 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,387,217 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,918,435 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,568,732 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,558,008 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $7,656,298 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $8,685,547 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,172216,504$3,601,171
20161,451272,918$4,415,156
20171,477279,847$4,332,051
20181,353301,405$5,302,929
20191,359307,875$6,387,217
20201,321328,194$6,918,435
20211,437386,407$7,568,732
20221,551519,400$7,558,008
20231,572552,731$7,656,298
20241,604705,420$8,685,547

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.4M$4.7M2015 Drug cost: $1,526,677 (USD; Tot_Drug_Cst)2016 Drug cost: $2,564,606 (USD; Tot_Drug_Cst)2017 Drug cost: $1,965,720 (USD; Tot_Drug_Cst)2018 Drug cost: $2,618,130 (USD; Tot_Drug_Cst)2019 Drug cost: $2,509,967 (USD; Tot_Drug_Cst)2020 Drug cost: $2,813,107 (USD; Tot_Drug_Cst)2021 Drug cost: $3,530,047 (USD; Tot_Drug_Cst)2022 Drug cost: $4,456,496 (USD; Tot_Drug_Cst)2023 Drug cost: $4,458,730 (USD; Tot_Drug_Cst)2024 Drug cost: $4,709,539 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155875,150$1,526,677
20166445,119$2,564,606
20176624,884$1,965,720
20187616,434$2,618,130
20198096,590$2,509,967
20208116,642$2,813,107
20218786,314$3,530,047
20229386,748$4,456,496
20239256,597$4,458,730
20249466,598$4,709,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$118K$236K2016 Medicare payment: $178 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $494 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $23,849 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $28,060 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $235,890 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $36,906 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $22,230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $24,040 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $24,276 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R11$178
2017N/R21$494
2018N/R31$23,849
20191250$28,060
2020364504$235,890
20213359$36,906
2022N/R26$22,230
2023N/R26$24,040
2024N/R26$24,276

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more6051,017$141
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,2742,796$100
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle5893,348$65
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month4631,788$52
96372Injection of drug or substance under skin or into muscle8102,662$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RinvoqUpadacitinib802,640$547,442
Enbrel SureclickEtanercept692,016$506,658
Humira(Cf) PenAdalimumab471,330$312,902
RemicadeInfliximab381,288$268,955
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5027623$267,649

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R13$19,991
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R13$4,285

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.372$14,874Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.6$58,942Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shariar Cohen-Gadol, M.D.?

Tedicare shows public-source Medicare data for Shariar Cohen-Gadol, M.D. (NPI 1013054865), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shariar Cohen-Gadol, M.D. have ACO affiliation data?

Shariar Cohen-Gadol, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Shariar Cohen-Gadol, M.D.?

Shariar Cohen-Gadol, M.D. is linked to SHARIAR COHEN MD CORP (billing NPI 1831331073) in the available physician profile data.

Does Shariar Cohen-Gadol, M.D. have Open Payments data?

Shariar Cohen-Gadol, M.D. has 378 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.